{"entity":{"type":"insider","cik":"0001355189","url":"/insider/0001355189","json_url":"/insider/0001355189.json","name":"Wegman Thomas","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":51,"n_filings":27,"first":"2008-02-05","last":"2018-08-17","span_basis":"filed_date"},"name_variants":[{"name":"Wegman Thomas","source":"filing","n_filings":27,"first_seen":"2008-02-05","last_seen":"2018-08-17"}],"transactions":[{"id":6819719,"accession":"0001062993-18-003490","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-18-003490","line_url":"/filing/0001062993-18-003490#line-2","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001355189","owner_name":"Wegman Thomas","owner_url":"/insider/0001355189","role":"Director, Officer (President), Ten percent owner","officer_title":"President","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":51.8912,"price_display":"51.89","price_state":"stated","total_value":129728.0,"total_display":"129,728.00","shares_owned_after":947473.0,"shares_owned_after_display":"947,473","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-08-17","filed_date":"2018-08-17","scope":"insider"},{"id":6819714,"accession":"0001062993-18-003490","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-18-003490","line_url":"/filing/0001062993-18-003490#line-1","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001355189","owner_name":"Wegman Thomas","owner_url":"/insider/0001355189","role":"Director, Officer (President), Ten percent owner","officer_title":"President","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21092.0,"shares_display":"21,092","price_per_share":51.2311,"price_display":"51.23","price_state":"stated","total_value":1080566.3612,"total_display":"1,080,566.36","shares_owned_after":291327.0,"shares_owned_after_display":"291,327","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-16","filed_date":"2018-08-17","scope":"insider"},{"id":6438526,"accession":"0001062993-18-003464","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-18-003464","line_url":"/filing/0001062993-18-003464#line-2","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001355189","owner_name":"Wegman Thomas","owner_url":"/insider/0001355189","role":"Director, Officer (President)","officer_title":"President","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7921.0,"shares_display":"7,921","price_per_share":50.0008,"price_display":"50.00","price_state":"stated","total_value":396056.3368,"total_display":"396,056.34","shares_owned_after":312419.0,"shares_owned_after_display":"312,419","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-15","filed_date":"2018-08-15","scope":"insider"},{"id":6438524,"accession":"0001062993-18-003464","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-18-003464","line_url":"/filing/0001062993-18-003464#line-1","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001355189","owner_name":"Wegman Thomas","owner_url":"/insider/0001355189","role":"Director, Officer (President)","officer_title":"President","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15987.0,"shares_display":"15,987","price_per_share":51.207,"price_display":"51.21","price_state":"stated","total_value":818646.309,"total_display":"818,646.31","shares_owned_after":320340.0,"shares_owned_after_display":"320,340","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-14","filed_date":"2018-08-15","scope":"insider"},{"id":9219068,"accession":"0001062993-17-000507","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-17-000507","line_url":"/filing/0001062993-17-000507#line-1","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001355189","owner_name":"Wegman Thomas","owner_url":"/insider/0001355189","role":"Director, Officer (President), Ten percent owner","officer_title":"President","security_title":"Common Stock, $.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":49.5408,"price_display":"49.54","price_state":"stated","total_value":743112.0,"total_display":"743,112.00","shares_owned_after":277549.0,"shares_owned_after_display":"277,549","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-08","filed_date":"2017-02-03","scope":"insider"},{"id":2867313,"accession":"0001062993-16-012691","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-16-012691","line_url":"/filing/0001062993-16-012691#line-1","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001355189","owner_name":"Wegman Thomas","owner_url":"/insider/0001355189","role":"Director, Officer (President), Ten percent owner","officer_title":"President","security_title":"Common Stock, $.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":49.5408,"price_display":"49.54","price_state":"stated","total_value":743112.0,"total_display":"743,112.00","shares_owned_after":930879.0,"shares_owned_after_display":"930,879","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-08","filed_date":"2016-12-13","scope":"insider"},{"id":9219066,"accession":"0001062993-17-000505","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-17-000505","line_url":"/filing/0001062993-17-000505#line-2","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001355189","owner_name":"Wegman Thomas","owner_url":"/insider/0001355189","role":"Director, Officer (President), Ten percent owner","officer_title":"President","security_title":"Common Stock, $.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8945.0,"shares_display":"8,945","price_per_share":48.3161,"price_display":"48.32","price_state":"stated","total_value":432187.5145,"total_display":"432,187.51","shares_owned_after":292549.0,"shares_owned_after_display":"292,549","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-29","filed_date":"2017-02-03","scope":"insider"},{"id":3109947,"accession":"0001062993-16-012536","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-16-012536","line_url":"/filing/0001062993-16-012536#line-1","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001355189","owner_name":"Wegman Thomas","owner_url":"/insider/0001355189","role":"Director, Officer (President), Ten percent owner","officer_title":"President","security_title":"Common Stock, $.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":48.0832,"price_display":"48.08","price_state":"stated","total_value":480832.0,"total_display":"480,832.00","shares_owned_after":949973.0,"shares_owned_after_display":"949,973","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-11-29","filed_date":"2016-11-29","scope":"insider"},{"id":2420384,"accession":"0001062993-16-012532","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-16-012532","line_url":"/filing/0001062993-16-012532#line-2","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001355189","owner_name":"Wegman Thomas","owner_url":"/insider/0001355189","role":"Director, Officer (President), Ten percent owner","officer_title":"President","security_title":"Common Stock, $.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8945.0,"shares_display":"8,945","price_per_share":48.3161,"price_display":"48.32","price_state":"stated","total_value":432187.5145,"total_display":"432,187.51","shares_owned_after":955879.0,"shares_owned_after_display":"955,879","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-29","filed_date":"2016-11-29","scope":"insider"},{"id":9219067,"accession":"0001062993-17-000505","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-17-000505","line_url":"/filing/0001062993-17-000505#line-1","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001355189","owner_name":"Wegman Thomas","owner_url":"/insider/0001355189","role":"Director, Officer (President), Ten percent owner","officer_title":"President","security_title":"Common Stock, $.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11055.0,"shares_display":"11,055","price_per_share":48.0369,"price_display":"48.04","price_state":"stated","total_value":531047.9295,"total_display":"531,047.93","shares_owned_after":301494.0,"shares_owned_after_display":"301,494","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-28","filed_date":"2017-02-03","scope":"insider"},{"id":2420379,"accession":"0001062993-16-012532","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-16-012532","line_url":"/filing/0001062993-16-012532#line-1","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001355189","owner_name":"Wegman Thomas","owner_url":"/insider/0001355189","role":"Director, Officer (President), Ten percent owner","officer_title":"President","security_title":"Common Stock, $.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11055.0,"shares_display":"11,055","price_per_share":48.0369,"price_display":"48.04","price_state":"stated","total_value":531047.9295,"total_display":"531,047.93","shares_owned_after":964824.0,"shares_owned_after_display":"964,824","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-28","filed_date":"2016-11-29","scope":"insider"},{"id":2946751,"accession":"0001062993-16-011507","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-16-011507","line_url":"/filing/0001062993-16-011507#line-1","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001355189","owner_name":"Wegman Thomas","owner_url":"/insider/0001355189","role":"Director, Officer (President), Ten percent owner","officer_title":"President","security_title":"Common Stock, $.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3100.0,"shares_display":"3,100","price_per_share":41.21,"price_display":"41.21","price_state":"stated","total_value":127751.0,"total_display":"127,751.00","shares_owned_after":959973.0,"shares_owned_after_display":"959,973","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-09-15","filed_date":"2016-09-16","scope":"insider"},{"id":3109928,"accession":"0001062993-16-011440","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-16-011440","line_url":"/filing/0001062993-16-011440#line-1","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001355189","owner_name":"Wegman Thomas","owner_url":"/insider/0001355189","role":"Director, Officer (President), Ten percent owner","officer_title":"President","security_title":"Common Stock, $.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3605.0,"shares_display":"3,605","price_per_share":37.545,"price_display":"37.54","price_state":"stated","total_value":135349.725,"total_display":"135,349.72","shares_owned_after":963073.0,"shares_owned_after_display":"963,073","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-09-13","filed_date":"2016-09-13","scope":"insider"},{"id":3035869,"accession":"0001062993-16-011377","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-16-011377","line_url":"/filing/0001062993-16-011377#line-2","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001355189","owner_name":"Wegman Thomas","owner_url":"/insider/0001355189","role":"Director, Officer (President), Ten percent owner","officer_title":"President","security_title":"Common Stock, $.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1266.0,"shares_display":"1,266","price_per_share":37.5,"price_display":"37.50","price_state":"stated","total_value":47475.0,"total_display":"47,475.00","shares_owned_after":966678.0,"shares_owned_after_display":"966,678","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-09-02","filed_date":"2016-09-02","scope":"insider"},{"id":3035863,"accession":"0001062993-16-011377","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-16-011377","line_url":"/filing/0001062993-16-011377#line-1","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001355189","owner_name":"Wegman Thomas","owner_url":"/insider/0001355189","role":"Director, Officer (President), Ten percent owner","officer_title":"President","security_title":"Common Stock, $.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7935.0,"shares_display":"7,935","price_per_share":37.533,"price_display":"37.53","price_state":"stated","total_value":297824.355,"total_display":"297,824.36","shares_owned_after":967944.0,"shares_owned_after_display":"967,944","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-09-01","filed_date":"2016-09-02","scope":"insider"},{"id":3109923,"accession":"0001062993-16-011354","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-16-011354","line_url":"/filing/0001062993-16-011354#line-2","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001355189","owner_name":"Wegman Thomas","owner_url":"/insider/0001355189","role":"Director, Officer (President), Ten percent owner","officer_title":"President","security_title":"Common Stock, $.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2692.0,"shares_display":"2,692","price_per_share":37.5027,"price_display":"37.50","price_state":"stated","total_value":100957.2684,"total_display":"100,957.27","shares_owned_after":975879.0,"shares_owned_after_display":"975,879","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-08-30","filed_date":"2016-08-30","scope":"insider"},{"id":3109918,"accession":"0001062993-16-011354","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-16-011354","line_url":"/filing/0001062993-16-011354#line-1","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001355189","owner_name":"Wegman Thomas","owner_url":"/insider/0001355189","role":"Director, Officer (President), Ten percent owner","officer_title":"President","security_title":"Common Stock, $.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1607.0,"shares_display":"1,607","price_per_share":37.6107,"price_display":"37.61","price_state":"stated","total_value":60440.3949,"total_display":"60,440.39","shares_owned_after":978571.0,"shares_owned_after_display":"978,571","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-08-29","filed_date":"2016-08-30","scope":"insider"},{"id":2059526,"accession":"0001062993-16-011291","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-16-011291","line_url":"/filing/0001062993-16-011291#line-2","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001355189","owner_name":"Wegman Thomas","owner_url":"/insider/0001355189","role":"Director, Officer (President), Ten percent owner","officer_title":"President","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4173.0,"shares_display":"4,173","price_per_share":38.0773,"price_display":"38.08","price_state":"stated","total_value":158896.5729,"total_display":"158,896.57","shares_owned_after":187549.0,"shares_owned_after_display":"187,549","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-24","filed_date":"2016-08-24","scope":"insider"},{"id":2059524,"accession":"0001062993-16-011291","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-16-011291","line_url":"/filing/0001062993-16-011291#line-1","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001355189","owner_name":"Wegman Thomas","owner_url":"/insider/0001355189","role":"Director, Officer (President), Ten percent owner","officer_title":"President","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4100.0,"shares_display":"4,100","price_per_share":38.6048,"price_display":"38.60","price_state":"stated","total_value":158279.68,"total_display":"158,279.68","shares_owned_after":191722.0,"shares_owned_after_display":"191,722","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-23","filed_date":"2016-08-24","scope":"insider"},{"id":3109889,"accession":"0001062993-16-009882","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001062993-16-009882","line_url":"/filing/0001062993-16-009882#line-8","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001355189","owner_name":"Wegman Thomas","owner_url":"/insider/0001355189","role":"Director, Officer (President), Ten percent owner","officer_title":"President","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24750.0,"shares_display":"24,750","price_per_share":33.0,"price_display":"33.00","price_state":"stated","total_value":816750.0,"total_display":"816,750.00","shares_owned_after":980178.0,"shares_owned_after_display":"980,178","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-05-18","filed_date":"2016-05-19","scope":"insider"},{"id":3109883,"accession":"0001062993-16-009882","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001062993-16-009882","line_url":"/filing/0001062993-16-009882#line-7","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001355189","owner_name":"Wegman Thomas","owner_url":"/insider/0001355189","role":"Director, Officer (President), Ten percent owner","officer_title":"President","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24750.0,"shares_display":"24,750","price_per_share":33.0,"price_display":"33.00","price_state":"stated","total_value":816750.0,"total_display":"816,750.00","shares_owned_after":195822.0,"shares_owned_after_display":"195,822","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-18","filed_date":"2016-05-19","scope":"insider"},{"id":3109877,"accession":"0001062993-16-009882","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001062993-16-009882","line_url":"/filing/0001062993-16-009882#line-6","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001355189","owner_name":"Wegman Thomas","owner_url":"/insider/0001355189","role":"Director, Officer (President), Ten percent owner","officer_title":"President","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":150.0,"shares_display":"150","price_per_share":34.14,"price_display":"34.14","price_state":"stated","total_value":5121.0,"total_display":"5,121.00","shares_owned_after":1004978.0,"shares_owned_after_display":"1,004,978","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-05-18","filed_date":"2016-05-19","scope":"insider"},{"id":3109873,"accession":"0001062993-16-009882","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001062993-16-009882","line_url":"/filing/0001062993-16-009882#line-5","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001355189","owner_name":"Wegman Thomas","owner_url":"/insider/0001355189","role":"Director, Officer (President), Ten percent owner","officer_title":"President","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":150.0,"shares_display":"150","price_per_share":34.14,"price_display":"34.14","price_state":"stated","total_value":5121.0,"total_display":"5,121.00","shares_owned_after":220622.0,"shares_owned_after_display":"220,622","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-18","filed_date":"2016-05-19","scope":"insider"},{"id":3109867,"accession":"0001062993-16-009882","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001062993-16-009882","line_url":"/filing/0001062993-16-009882#line-4","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001355189","owner_name":"Wegman Thomas","owner_url":"/insider/0001355189","role":"Director, Officer (President), Ten percent owner","officer_title":"President","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50.0,"shares_display":"50","price_per_share":34.11,"price_display":"34.11","price_state":"stated","total_value":1705.5,"total_display":"1,705.50","shares_owned_after":1004928.0,"shares_owned_after_display":"1,004,928","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-05-18","filed_date":"2016-05-19","scope":"insider"},{"id":3109860,"accession":"0001062993-16-009882","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001062993-16-009882","line_url":"/filing/0001062993-16-009882#line-3","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001355189","owner_name":"Wegman Thomas","owner_url":"/insider/0001355189","role":"Director, Officer (President), Ten percent owner","officer_title":"President","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50.0,"shares_display":"50","price_per_share":34.11,"price_display":"34.11","price_state":"stated","total_value":1705.5,"total_display":"1,705.50","shares_owned_after":220572.0,"shares_owned_after_display":"220,572","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-18","filed_date":"2016-05-19","scope":"insider"},{"id":3109853,"accession":"0001062993-16-009882","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-16-009882","line_url":"/filing/0001062993-16-009882#line-2","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001355189","owner_name":"Wegman Thomas","owner_url":"/insider/0001355189","role":"Director, Officer (President), Ten percent owner","officer_title":"President","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50.0,"shares_display":"50","price_per_share":33.8,"price_display":"33.80","price_state":"stated","total_value":1690.0,"total_display":"1,690.00","shares_owned_after":1005128.0,"shares_owned_after_display":"1,005,128","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-05-18","filed_date":"2016-05-19","scope":"insider"},{"id":3109838,"accession":"0001062993-16-009882","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-16-009882","line_url":"/filing/0001062993-16-009882#line-1","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001355189","owner_name":"Wegman Thomas","owner_url":"/insider/0001355189","role":"Director, Officer (President), Ten percent owner","officer_title":"President","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50.0,"shares_display":"50","price_per_share":33.8,"price_display":"33.80","price_state":"stated","total_value":1690.0,"total_display":"1,690.00","shares_owned_after":220772.0,"shares_owned_after_display":"220,772","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-18","filed_date":"2016-05-19","scope":"insider"},{"id":8939845,"accession":"0001062993-15-006473","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-15-006473","line_url":"/filing/0001062993-15-006473#line-2","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001355189","owner_name":"Wegman Thomas","owner_url":"/insider/0001355189","role":"Director, Officer (President & CEO), Ten percent owner","officer_title":"President & CEO","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":267.0,"shares_display":"267","price_per_share":50.0,"price_display":"50.00","price_state":"stated","total_value":13350.0,"total_display":"13,350.00","shares_owned_after":120822.0,"shares_owned_after_display":"120,822","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-30","filed_date":"2015-11-30","scope":"insider"},{"id":8939842,"accession":"0001062993-15-006473","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-15-006473","line_url":"/filing/0001062993-15-006473#line-1","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001355189","owner_name":"Wegman Thomas","owner_url":"/insider/0001355189","role":"Director, Officer (President & CEO), Ten percent owner","officer_title":"President & CEO","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1733.0,"shares_display":"1,733","price_per_share":50.0,"price_display":"50.00","price_state":"stated","total_value":86650.0,"total_display":"86,650.00","shares_owned_after":121089.0,"shares_owned_after_display":"121,089","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-27","filed_date":"2015-11-30","scope":"insider"},{"id":8798402,"accession":"0001062993-15-006419","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-15-006419","line_url":"/filing/0001062993-15-006419#line-2","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001355189","owner_name":"Wegman Thomas","owner_url":"/insider/0001355189","role":"Director, Officer (President & CEO), Ten percent owner","officer_title":"President & CEO","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9923.0,"shares_display":"9,923","price_per_share":50.1039,"price_display":"50.10","price_state":"stated","total_value":497180.9997,"total_display":"497,181.00","shares_owned_after":122822.0,"shares_owned_after_display":"122,822","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-23","filed_date":"2015-11-24","scope":"insider"},{"id":8798401,"accession":"0001062993-15-006419","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-15-006419","line_url":"/filing/0001062993-15-006419#line-1","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001355189","owner_name":"Wegman Thomas","owner_url":"/insider/0001355189","role":"Director, Officer (President & CEO), Ten percent owner","officer_title":"President & CEO","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4077.0,"shares_display":"4,077","price_per_share":50.048,"price_display":"50.05","price_state":"stated","total_value":204045.696,"total_display":"204,045.70","shares_owned_after":132745.0,"shares_owned_after_display":"132,745","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-20","filed_date":"2015-11-24","scope":"insider"},{"id":8356372,"accession":"0001062993-15-006347","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-15-006347","line_url":"/filing/0001062993-15-006347#line-2","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001355189","owner_name":"Wegman Thomas","owner_url":"/insider/0001355189","role":"Director, Officer (President & CEO), Ten percent owner","officer_title":"President & CEO","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":50.0892,"price_display":"50.09","price_state":"stated","total_value":500892.0,"total_display":"500,892.00","shares_owned_after":136822.0,"shares_owned_after_display":"136,822","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-18","filed_date":"2015-11-19","scope":"insider"},{"id":8356366,"accession":"0001062993-15-006347","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-15-006347","line_url":"/filing/0001062993-15-006347#line-1","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001355189","owner_name":"Wegman Thomas","owner_url":"/insider/0001355189","role":"Director, Officer (President & CEO), Ten percent owner","officer_title":"President & CEO","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":849.0,"shares_display":"849","price_per_share":50.0,"price_display":"50.00","price_state":"stated","total_value":42450.0,"total_display":"42,450.00","shares_owned_after":146822.0,"shares_owned_after_display":"146,822","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-17","filed_date":"2015-11-19","scope":"insider"},{"id":8898641,"accession":"0001062993-15-006258","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-15-006258","line_url":"/filing/0001062993-15-006258#line-2","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001355189","owner_name":"Wegman Thomas","owner_url":"/insider/0001355189","role":"Director, Officer (President & CEO), Ten percent owner","officer_title":"President & CEO","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3136.0,"shares_display":"3,136","price_per_share":51.4643,"price_display":"51.46","price_state":"stated","total_value":161392.0448,"total_display":"161,392.04","shares_owned_after":147671.0,"shares_owned_after_display":"147,671","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-16","filed_date":"2015-11-16","scope":"insider"},{"id":8898638,"accession":"0001062993-15-006258","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-15-006258","line_url":"/filing/0001062993-15-006258#line-1","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001355189","owner_name":"Wegman Thomas","owner_url":"/insider/0001355189","role":"Director, Officer (President & CEO), Ten percent owner","officer_title":"President & CEO","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24015.0,"shares_display":"24,015","price_per_share":52.5635,"price_display":"52.56","price_state":"stated","total_value":1262312.4525,"total_display":"1,262,312.45","shares_owned_after":150807.0,"shares_owned_after_display":"150,807","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-13","filed_date":"2015-11-16","scope":"insider"},{"id":9219056,"accession":"0001062993-15-002354","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001062993-15-002354","line_url":"/filing/0001062993-15-002354#line-3","is_derivative":false,"issuer_cik":"0001355189","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0001355189","owner_cik":"0001355189","owner_name":"Wegman Thomas","owner_url":"/insider/0001355189","role":"Director, Officer (President and Chief Executive), Ten percent owner","officer_title":"President and Chief Executive","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":38.5,"price_display":"38.50","price_state":"stated","total_value":308000.0,"total_display":"308,000.00","shares_owned_after":174822.0,"shares_owned_after_display":"174,822","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-14","filed_date":"2015-05-04","scope":"insider"},{"id":6630126,"accession":"0001062993-14-006713","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001062993-14-006713","line_url":"/filing/0001062993-14-006713#line-3","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001355189","owner_name":"Wegman Thomas","owner_url":"/insider/0001355189","role":"Director, Officer (President and Chief Executive), Ten percent owner","officer_title":"President and Chief Executive","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":38.5,"price_display":"38.50","price_state":"stated","total_value":308000.0,"total_display":"308,000.00","shares_owned_after":177222.0,"shares_owned_after_display":"177,222","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-14","filed_date":"2014-11-14","scope":"insider"},{"id":9219058,"accession":"0001062993-15-002354","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-15-002354","line_url":"/filing/0001062993-15-002354#line-2","is_derivative":false,"issuer_cik":"0001355189","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0001355189","owner_cik":"0001355189","owner_name":"Wegman Thomas","owner_url":"/insider/0001355189","role":"Director, Officer (President and Chief Executive), Ten percent owner","officer_title":"President and Chief Executive","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4300.0,"shares_display":"4,300","price_per_share":39.0364,"price_display":"39.04","price_state":"stated","total_value":167856.52,"total_display":"167,856.52","shares_owned_after":185222.0,"shares_owned_after_display":"185,222","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-13","filed_date":"2015-05-04","scope":"insider"},{"id":6630121,"accession":"0001062993-14-006713","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-14-006713","line_url":"/filing/0001062993-14-006713#line-2","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001355189","owner_name":"Wegman Thomas","owner_url":"/insider/0001355189","role":"Director, Officer (President and Chief Executive), Ten percent owner","officer_title":"President and Chief Executive","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4300.0,"shares_display":"4,300","price_per_share":39.0364,"price_display":"39.04","price_state":"stated","total_value":167856.52,"total_display":"167,856.52","shares_owned_after":185222.0,"shares_owned_after_display":"185,222","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-13","filed_date":"2014-11-14","scope":"insider"},{"id":9219057,"accession":"0001062993-15-002354","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-15-002354","line_url":"/filing/0001062993-15-002354#line-1","is_derivative":false,"issuer_cik":"0001355189","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0001355189","owner_cik":"0001355189","owner_name":"Wegman Thomas","owner_url":"/insider/0001355189","role":"Director, Officer (President and Chief Executive), Ten percent owner","officer_title":"President and Chief Executive","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27700.0,"shares_display":"27,700","price_per_share":39.0771,"price_display":"39.08","price_state":"stated","total_value":1082435.67,"total_display":"1,082,435.67","shares_owned_after":189522.0,"shares_owned_after_display":"189,522","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-12","filed_date":"2015-05-04","scope":"insider"},{"id":6630115,"accession":"0001062993-14-006713","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-14-006713","line_url":"/filing/0001062993-14-006713#line-1","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001355189","owner_name":"Wegman Thomas","owner_url":"/insider/0001355189","role":"Director, Officer (President and Chief Executive), Ten percent owner","officer_title":"President and Chief Executive","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27700.0,"shares_display":"27,700","price_per_share":39.0771,"price_display":"39.08","price_state":"stated","total_value":1082435.67,"total_display":"1,082,435.67","shares_owned_after":189522.0,"shares_owned_after_display":"189,522","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-12","filed_date":"2014-11-14","scope":"insider"},{"id":9177681,"accession":"0001062993-11-002525","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-11-002525","line_url":"/filing/0001062993-11-002525#line-1","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001355189","owner_name":"Wegman Thomas","owner_url":"/insider/0001355189","role":"Director, Officer (President), Ten percent owner","officer_title":"President","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":22.25,"price_display":"22.25","price_state":"stated","total_value":445000.0,"total_display":"445,000.00","shares_owned_after":163644.0,"shares_owned_after_display":"163,644","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-06-06","filed_date":"2011-06-09","scope":"insider"},{"id":7761384,"accession":"0001062993-10-003047","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-10-003047","line_url":"/filing/0001062993-10-003047#line-1","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001355189","owner_name":"Wegman Thomas","owner_url":"/insider/0001355189","role":"Director, Officer (President), Ten percent owner","officer_title":"President","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":150000.0,"shares_display":"150,000","price_per_share":23.5,"price_display":"23.50","price_state":"stated","total_value":3525000.0,"total_display":"3,525,000.00","shares_owned_after":1005179.0,"shares_owned_after_display":"1,005,179","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-09-13","filed_date":"2010-09-15","scope":"insider"},{"id":6008751,"accession":"0001204459-09-002289","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001204459-09-002289","line_url":"/filing/0001204459-09-002289#line-1","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001355189","owner_name":"Wegman Thomas","owner_url":"/insider/0001355189","role":"Director, Officer (President), Ten percent owner","officer_title":"President","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":3000000.0,"total_display":"3,000,000.00","shares_owned_after":1155179.0,"shares_owned_after_display":"1,155,179","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-11-27","filed_date":"2009-12-01","scope":"insider"},{"id":5617363,"accession":"0001204459-09-001692","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001204459-09-001692","line_url":"/filing/0001204459-09-001692#line-1","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001355189","owner_name":"Wegman Thomas","owner_url":"/insider/0001355189","role":"Director, Officer (President), Ten percent owner","officer_title":"President","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":24.0,"price_display":"24.00","price_state":"stated","total_value":2400000.0,"total_display":"2,400,000.00","shares_owned_after":1255179.0,"shares_owned_after_display":"1,255,179","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-09-15","filed_date":"2009-09-17","scope":"insider"},{"id":5692942,"accession":"0001204459-09-000229","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001204459-09-000229","line_url":"/filing/0001204459-09-000229#line-1","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC.NGM","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001355189","owner_name":"Wegman Thomas","owner_url":"/insider/0001355189","role":"Director, Officer (President), Ten percent owner","officer_title":"President","security_title":"Common Stock. $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":45000.0,"shares_display":"45,000","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":900000.0,"total_display":"900,000.00","shares_owned_after":1406123.0,"shares_owned_after_display":"1,406,123","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-02-05","filed_date":"2009-02-11","scope":"insider"},{"id":9211940,"accession":"0000950120-08-000151","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950120-08-000151","line_url":"/filing/0000950120-08-000151#line-1","is_derivative":false,"issuer_cik":"0001355189","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC.OB","issuer_name_source":null,"issuer_url":"/issuer/0001355189","owner_cik":"0001355189","owner_name":"Wegman Thomas","owner_url":"/insider/0001355189","role":"Director, Officer (President), Ten percent owner","officer_title":"President","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200000.0,"shares_display":"200,000","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":2200000.0,"total_display":"2,200,000.00","shares_owned_after":1075941.0,"shares_owned_after_display":"1,075,941","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-04-07","filed_date":"2008-04-09","scope":"insider"},{"id":3962922,"accession":"0000950120-08-000145","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950120-08-000145","line_url":"/filing/0000950120-08-000145#line-1","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC.OB","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001355189","owner_name":"Wegman Thomas","owner_url":"/insider/0001355189","role":"Director, Officer (President), Ten percent owner","officer_title":"President","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200000.0,"shares_display":"200,000","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":2200000.0,"total_display":"2,200,000.00","shares_owned_after":1281055.0,"shares_owned_after_display":"1,281,055","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-04-07","filed_date":"2008-04-09","scope":"insider"},{"id":3528330,"accession":"0000950120-08-000056","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950120-08-000056","line_url":"/filing/0000950120-08-000056#line-4","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC.OB","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001355189","owner_name":"Wegman Thomas","owner_url":"/insider/0001355189","role":"Director, Officer (President), Ten percent owner","officer_title":"President","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":205114.0,"shares_display":"205,114","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":2461368.0,"total_display":"2,461,368.00","shares_owned_after":1275941.0,"shares_owned_after_display":"1,275,941","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-02-01","filed_date":"2008-02-05","scope":"insider"},{"id":3528328,"accession":"0000950120-08-000056","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950120-08-000056","line_url":"/filing/0000950120-08-000056#line-3","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC.OB","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001355189","owner_name":"Wegman Thomas","owner_url":"/insider/0001355189","role":"Director, Officer (President), Ten percent owner","officer_title":"President","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":1200000.0,"total_display":"1,200,000.00","shares_owned_after":1275941.0,"shares_owned_after_display":"1,275,941","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-02-01","filed_date":"2008-02-05","scope":"insider"}],"next_cursor":"2008-02-01|3528328","ledger_fault":false,"count":{"value":51,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":51,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":51},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000875622","name":"BIOSPECIFICS TECHNOLOGIES CORP","url":"/issuer/0000875622","role":"Director, Officer (President), Ten percent owner","n_filings":27,"first_seen":"2008-02-05","last_seen":"2018-08-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001355189","retrieved_at":"2026-08-21T23:14:45+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}